Evaluation of the susceptibility of pathogenic Candida species to fluconazole

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 12, 1997, Pages 924-928

  Bille, J ^a   Glauser, M P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ARTICLE; CANDIDA; CANDIDA ALBICANS; DRUG SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; EVALUATION STUDIES; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

EID: 0031441836     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01700561     Document Type: Article

References (12)

1. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeast. Tentative standard M27-T. NCCLS, Villanova, PA, 1995.
2. Polanco AM, Rodriguez-Tudela JL, Baquero F, Sanchez-Sousa A, Martinez-Suarez JV: Improved method of determining the susceptibility of Candida albicans to fluconazole. Journal of Antimicrobial Chemotherapy 1995, 35: 155-159.
3. Fournier C, Gaspar A, Boillot F, Villard J: Evaluation of a broth microdilution antifungal susceptibility test with a pH indicator: comparison with the broth macrodilution procedures. Journal of Antimicrobial Chemotherapy 1995, 35: 373-380.
4. Rodriguez-Tudela JL, Martinez-Suarez JV: Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI-2% glucose on the selection of end-point criteria. Journal of Antimicrobial Chemotherapy 1995, 35: 739-749.
5. Espinel-Ingroff A, Rodriguez-Tudela JL, Martinez-Suarez JV: Comparison of two microdilution procedures with the proposed NCCLS reference macro-dilution method M27-P for in vitro testing of fluconazole resistant and susceptible isolates of Candida albicans. Journal of Clinical Microbiology 1995, 33: 3154-3158.
6. Colombo J, Barchiesi F, McGough DA, Fotherfill AW, Rinaldi MG: Evaluation of the E-test system versus a microtitre broth method for antifungal susceptibility testing of yeast against fluconazole and itraconazole. Antimicrobial Agents and Chemotherapy 1995, 36: 93-100.
7. Troillet N, Durussel C, Bille J, Glauser MP, Chave JP: Correlation between in vitro susceptibility of Candida albicans and fluconazole resistant oropharyngeal candidiasis in HIV-infected patients. European Journal of Clinical Microbiology & Infectious Diseases 1993, 12: 911-915.
8. Barry A, Brown S: Fluconazole disk diffusion procedure for determining susceptibility of Candida species. Journal of Clinical Microbiology 1996, 34: 2154-2157.
9. Rex J, Pfaller MA, Barry AL, Nelson PW, Webb CD: Antifungal susceptibility testing of isolates from a randomized multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia. Antimicrobial Agents and Chemotherapy 1995, 39: 40-44.
10. van't Wout JW: Fluconazole treatment of candidal infections caused by non-albicans Candida species. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 238-242.
11. Ghannoum M, Rex JH, Galgiani J: Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. Journal of Clinical Microbiology 1996, 34: 489-495.
12. Rex J, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry A: Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro - in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clinical Infectious Diseases 1997, 24: 235-247.